Authors

1. Wood , Kathryn A.
2. Ko , Yi-An
3. Han , Feier
4. Thunell , Johanna
5. Zissimopoulos , Julie
6. Wharton , Whitney

Abstract

We found similar risks of cognitive decline between those on NOACs or warfarin. Future studies should consider effects of age, length of time from AF diagnosis, and OAC adherence on this risk.